Marker Therapeutics Provides Updates of its Lead Clinical Programs

Go back to Marker Therapeutics Provides Updates of its Lead Clinical Programs
(NASDAQ: MRKR) Delayed: 1.47 +0.02 (1.38%)
Previous Close $1.45    52 Week High
Open $1.46    52 Week Low
Day High $1.50    P/E N/A 
Day Low $1.44    EPS
Volume 65,844